A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Actym Therapeutics, Inc.
University of Virginia
Seagen Inc.
Sotio Biotech Inc.
Aminex Therapeutics, Inc.
pharmaand GmbH
Eli Lilly and Company
Incyte Corporation
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
CureOne
University Health Network, Toronto